Survival analysis of dogs with advanced primary lung carcinoma treated by metronomic cyclophosphamide, piroxicam and thalidomide

著录项

• 来源
  《Veterinary and Comparative Oncology》 |2018年第3期|共10页
• 作者

  Polton G.; Finotello R.; Sabattini S.; Rossi F.; Laganga P.; Vasconi M. E.; Barbanera A.; Stiborova K.; Rohrer Bley C.; Marconato L.;

  展开▼
• 作者单位

  North Downs Specialist ReferralsBrewerstreet Dairy Business ParkSurrey UK;

  Department of Small Animal Clinical ScienceInstitute of Veterinary Science Faculty of Health and Life Science University of LiverpoolNeston UK;

  Department of Veterinary Medical SciencesUniversity of BolognaBologna Italy;

  Centro Oncologico VeterinarioSasso Marconi Italy;

  Centro Oncologico VeterinarioSasso Marconi Italy;

  Centro Veterinario TorineseTurin Italy;

  Centro Oncologico VeterinarioSasso Marconi Italy;

  Department of Small Animal Clinical ScienceInstitute of Veterinary Science Faculty of Health and Life Science University of LiverpoolNeston UK;

  Division of Radiation OncologyVetsuisse‐Faculty University of ZurichZürich Switzerland;

  Centro Oncologico VeterinarioSasso Marconi Italy;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 动物医学（兽医学）;
• 关键词

  advanced stage; canine; dog; lung carcinoma; metronomic chemotherapy; prognosis; thalidomide;

  机译：高级阶段;犬;狗;肺癌;度量组化疗;预后;沙利度胺;